ATE141288T1 - Melaninkonzentrierende hormone und dns die diese expremieren - Google Patents

Melaninkonzentrierende hormone und dns die diese expremieren

Info

Publication number
ATE141288T1
ATE141288T1 AT90905279T AT90905279T ATE141288T1 AT E141288 T1 ATE141288 T1 AT E141288T1 AT 90905279 T AT90905279 T AT 90905279T AT 90905279 T AT90905279 T AT 90905279T AT E141288 T1 ATE141288 T1 AT E141288T1
Authority
AT
Austria
Prior art keywords
mch
glu
peptides
ala
rat
Prior art date
Application number
AT90905279T
Other languages
English (en)
Inventor
Joan Vaughan
Wolfgang Hermann Fischer
Jean Edouard Rivier
Jean-Louis Marie C O Ipm Nahon
Lucioles Des
Francoise Genevieve C O Presse
Des Lucioles Route
Wylie Walker Vale Jr
Original Assignee
Salk Inst For Biological Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi
Application granted granted Critical
Publication of ATE141288T1 publication Critical patent/ATE141288T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/854Glands

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT90905279T 1989-03-22 1990-03-20 Melaninkonzentrierende hormone und dns die diese expremieren ATE141288T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/326,984 US5049655A (en) 1989-03-22 1989-03-22 Melanin-concentrating hormones

Publications (1)

Publication Number Publication Date
ATE141288T1 true ATE141288T1 (de) 1996-08-15

Family

ID=23274624

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90905279T ATE141288T1 (de) 1989-03-22 1990-03-20 Melaninkonzentrierende hormone und dns die diese expremieren

Country Status (8)

Country Link
US (3) US5049655A (de)
EP (1) EP0464105B1 (de)
JP (1) JP2944202B2 (de)
AT (1) ATE141288T1 (de)
CA (1) CA2046900C (de)
DE (1) DE69028101T2 (de)
DK (1) DK0464105T3 (de)
WO (1) WO1990011295A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849708A (en) * 1995-06-06 1998-12-15 Joslin Diabetes Center, Inc. Promotion of eating behavior
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
AU1802000A (en) * 1998-12-28 2000-07-24 Takeda Chemical Industries Ltd. Screening method
GB9924351D0 (en) * 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
EP1255770A4 (de) * 2000-02-03 2004-12-08 Merck & Co Inc Analoge des melanin konzentrierenden hormons
US7220720B2 (en) * 2000-02-03 2007-05-22 Merk & Co., Inc. Melanin-concentrating hormone analogs
US6809104B2 (en) * 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
US20070135425A1 (en) * 2001-05-04 2007-06-14 Amgen Inc. Fused heterocyclic compounds
GB0112343D0 (en) * 2001-05-21 2001-07-11 Norske Stats Oljeselskap Well treatment
US7314861B2 (en) * 2001-05-31 2008-01-01 Merck & Co., Inc. Melanin-concentrating hormone analogs
CA2456964A1 (en) * 2001-08-08 2003-02-20 Merck & Co., Inc. Melanin-concentrating hormone antagonists
CA2473229A1 (en) * 2002-01-09 2003-07-24 Merck & Co., Inc. Selective melanin-concentrating hormone type -1 receptor agonists
KR20030066187A (ko) * 2002-02-05 2003-08-09 나드리화장품주식회사 미백 화장료 조성물
CN101134757A (zh) * 2002-11-06 2008-03-05 安姆根有限公司 稠合杂环化合物
CA2569782C (en) 2004-06-17 2011-09-27 Statoil Asa Prevention or reduction of particle migration in hydrocarbon formations
CA2569770C (en) * 2004-06-17 2012-02-21 Statoil Asa Water reductions in subterranean formations
CA2604220A1 (en) * 2005-04-26 2006-11-02 Rune Godoey Method of well treatment and construction
KR100839194B1 (ko) 2006-12-14 2008-06-17 부경대학교 산학협력단 양식 넙치의 멜라닌농축호르몬
GB2450502B (en) * 2007-06-26 2012-03-07 Statoil Asa Microbial enhanced oil recovery
EP2190453A2 (de) * 2007-09-11 2010-06-02 Mondobiotech Laboratories AG Verwendung von trp6-triptorelin und d-leu6-leuprolid als therapeutische mittel
WO2009043523A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Cortistatin 17 and neuropeptide 1 for use as therapeutic agent

Also Published As

Publication number Publication date
CA2046900A1 (en) 1990-09-23
US5449766A (en) 1995-09-12
JP2944202B2 (ja) 1999-08-30
DK0464105T3 (da) 1997-01-06
WO1990011295A1 (en) 1990-10-04
EP0464105A1 (de) 1992-01-08
DE69028101T2 (de) 1997-03-06
CA2046900C (en) 2000-08-22
JPH04503812A (ja) 1992-07-09
EP0464105A4 (en) 1992-08-12
US5530095A (en) 1996-06-25
US5049655A (en) 1991-09-17
DE69028101D1 (de) 1996-09-19
EP0464105B1 (de) 1996-08-14

Similar Documents

Publication Publication Date Title
ATE141288T1 (de) Melaninkonzentrierende hormone und dns die diese expremieren
Prinz et al. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products
Giancotti et al. Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures
Goldstein et al. Thymosins: chemistry and biological properties in health and disease
Savage et al. Epidermal growth factor and a new derivative: rapid isolation procedures and biological and chemical characterization
Thomas et al. Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1.
KR100345254B1 (ko) 생물학적샘플속의인터루킨12또는인터루킨12의p40아단위를검출하는방법
Madsen et al. Growth hormone stimulates the proliferation of cultured chondrocytes from rabbit ear and rat rib growth cartilage
Sato et al. Production of interleukin 1α-like factor and colony-stimulating factor by a squamous cell carcinoma of the thyroid (T3M-5) derived from a patient with hypercalcemia and leukocytosis
US7052684B2 (en) Methods of healing wounds and fibrotic disorders using IL-10
DE3485945T2 (de) Gereinigter transformierender wachstum-beta-faktor aus humanen plaketten und plazenten stammend.
DE69119879T2 (de) Epitheliocytenwachstumsbeschleuniger
US7008925B1 (en) Melanocortin 1 receptor selective compounds
DE60208692T2 (de) Interleukin -18 mutantenproteine, deren herstellung und verwendung
JP2010155859A (ja) 生物活性ケラチンタンパク質
DE69332413D1 (de) Interleukin-2 analoge mit niedriger toxizität zur verwendung in der immuntherapie
DK2913059T3 (en) Hitherto UNKNOWN PROCEDURE FOR TREATMENT OF SPINE INJURY USING HMGB1 FRAGMENT
JPH0649657B2 (ja) 創傷の治癒
DE69930662D1 (de) Humane rezeptortyrosinkinase
ES2173856T3 (es) Proceso para la preparacion de vectores geneticos para la expresion del factor de crecimiento nervioso en celulas eucariotas.
Bhartiya et al. Enhanced wound healing in animal models by interferon and an interferon inducer
JPS63122699A (ja) ペプチド
CA2566776C (en) Method for ameliorating an inflammatory skin condition
JPH03500529A (ja) 増殖因子
JP3160013B2 (ja) 新規ペプチド